---
title: "Kardigan Q2 FY26 net loss widens to $116.24 million; R&D expenses rise to $56.37 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295525374.md"
description: "Kardigan reported a widened Q2 FY26 net loss of $116.24 million, up from $57.45 million prior year. R&D expenses rose to $56.37 million due to increased clinical trial spending and headcount. Cash and investments grew to $660.69 million following IPO proceeds. G&A expenses decreased to $18.87 million. Pipeline updates include ongoing Phase 3 KINSHIP-DCM trials and targeted H1 2027 data for danicamtiv, ataciguat, and tonlamarsen."
datetime: "2026-08-11T11:01:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295525374.md)
  - [en](https://longbridge.com/en/news/295525374.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295525374.md)
generator: "portal-rs"
---

# Kardigan Q2 FY26 net loss widens to $116.24 million; R&D expenses rise to $56.37 million

-   Kardigan posted a Q2 net loss of USD 116.24 million, widening from USD 57.45 million a year earlier. \* R&D expense climbed to USD 56.37 million from USD 35.84 million, driven by higher clinical-trial spending and headcount growth. \* Cash, cash equivalents and investments rose to USD 660.69 million at June 30 from USD 335.49 million at Dec. 31, reflecting IPO proceeds. \* G&A expense eased to USD 18.87 million from USD 21.29 million, on the absence of a prior-year one-time integration bonus. \* Pipeline update: Phase 3 portion of KINSHIP-DCM is underway; Phase 2b topline data for danicamtiv, ataciguat, tonlamarsen targeted in H1 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kardigan Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260811514909) on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [KARD.US](https://longbridge.com/en/quote/KARD.US.md)

## Related News & Research

- [Kardigan, Inc. 2Q 2026: Net loss $116.2M, EPS $(4.61) — 10-Q Summary](https://longbridge.com/en/news/295528778.md)
- [Kardigan, Inc. (NASDAQ:KARD) Short Interest Up ∞ in June](https://longbridge.com/en/news/292899327.md)
- [Ton Strategy CFO, COO Sarah Olsen disposes of 217,450 common shares for $598,502.29](https://longbridge.com/en/news/296145892.md)
- [Ton Strategy Co director Oscar Suarez files initial beneficial ownership statement](https://longbridge.com/en/news/296264203.md)
- [Konsolidator removes security permissions from H1 2026 report in correction notice](https://longbridge.com/en/news/296313500.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**